Facetime with Phil
In part three of this video series, myMatrixx Chief Clinical Officer Phil Walls continues exploring pharmacovigilance and the specific ways it was incorporated into myRXAdvocate. To prioritize both patient safety and lower drug costs, myRXAdvocate uses data analytics and reporting to identify high risk patients and recommend safer and more cost-effective solutions. In particular, Phil shows how this program can help injured workers who have been prescribed high morphine-equivalent dosages of opioids.
For the fourth and final video introducing myRXAdvocate, myMatrixx Chief Clinical Officer Phil Walls shows how this program can help patients who require high-risk drugs, such as opioids. By using pharmacovigilance, myRXAdvocate can help identify the safest, most effective and lowest cost therapies to help mitigate the risks associated with opioids while still ensuring positive outcomes.